- Home
- CZNC vs MRVI Comparison
CZNC vs MRVI Comparison
Compare CZNC & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CZNC
- MRVI
- Stock Information
- Founded
- CZNC 1864
- MRVI 2014
- Country
- CZNC United States
- MRVI United States
- Employees
- CZNC N/A
- MRVI N/A
- Industry
- CZNC Major Banks
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- CZNC Finance
- MRVI Health Care
- Exchange
- CZNC Nasdaq
- MRVI Nasdaq
- Market Cap
- CZNC 286.0M
- MRVI 262.9M
- IPO Year
- CZNC N/A
- MRVI 2020
- Fundamental
- Price
- CZNC $19.10
- MRVI $1.98
- Analyst Decision
- CZNC
- MRVI Hold
- Analyst Count
- CZNC 0
- MRVI 9
- Target Price
- CZNC N/A
- MRVI $6.54
- AVG Volume (30 Days)
- CZNC 35.1K
- MRVI 1.7M
- Earning Date
- CZNC 04-23-2025
- MRVI 05-12-2025
- Dividend Yield
- CZNC 5.86%
- MRVI N/A
- EPS Growth
- CZNC 15.34
- MRVI N/A
- EPS
- CZNC 1.75
- MRVI N/A
- Revenue
- CZNC $108,114,000.00
- MRVI $259,185,000.00
- Revenue This Year
- CZNC $9.38
- MRVI N/A
- Revenue Next Year
- CZNC $3.77
- MRVI $14.23
- P/E Ratio
- CZNC $10.93
- MRVI N/A
- Revenue Growth
- CZNC 5.33
- MRVI N/A
- 52 Week Low
- CZNC $16.50
- MRVI $1.67
- 52 Week High
- CZNC $22.68
- MRVI $11.56
- Technical
- Relative Strength Index (RSI)
- CZNC 47.86
- MRVI 43.17
- Support Level
- CZNC $18.75
- MRVI $1.96
- Resistance Level
- CZNC $19.39
- MRVI $2.16
- Average True Range (ATR)
- CZNC 0.53
- MRVI 0.13
- MACD
- CZNC 0.06
- MRVI 0.04
- Stochastic Oscillator
- CZNC 38.79
- MRVI 47.67
About CZNC Citizens & Northern Corp
Citizens & Northern Corp is a community bank operating through its subsidiaries. It provides banking services, including deposit and loan products for personal and commercial customers. The bank also maintains a trust division that provides a wide range of financial services, such as 401(k) plans, retirement planning, estate planning, estate settlements and asset management.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.